Ulinastatin Inhibits the Proliferation, Invasion and Phenotypic Switching of PDGF-BB-Induced VSMCs via Akt/eNOS/NO/cGMP Signaling Pathway

References

• HuangY, LiT, GaoW, et al. Platelet-derived nanomotor coated balloon for atherosclerosis combination therapy. J Mater Chem B. 2020.
   Web of Science ®Google Scholar
• KyawT, PeterK, LiY, TippingP, TohBH, BobikA. Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges. Br J Pharmacol. 2017;174(22):3956–3972.28471481
   PubMed Web of Science ®Google Scholar
• ZhouL, LongJ, SunY, ChenW, QiuR, YuanD. Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE(-/-) mice and inhibits the activation of CD4(+) T cells. Nutr Metab (Lond). 2020;17(1):41. doi:10.1186/s12986-020-00461-z32508962
   PubMed Web of Science ®Google Scholar
• StevenS, FrenisK, OelzeM, et al. Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7092151. doi:10.1155/2019/709215131341533
   PubMed Web of Science ®Google Scholar
• VirmaniR, KolodgieFD, BurkeAP, FarbA, SchwartzSM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262–1275. doi:10.1161/01.ATV.20.5.126210807742
   PubMed Web of Science ®Google Scholar
• PugiaMJ, LottJA. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med. 2005;43(1):1–16. doi:10.1515/CCLM.2005.00115653436
   PubMed Web of Science ®Google Scholar
• PugiaMJ, ValdesR Jr, JortaniSA. Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement. Adv Clin Chem. 2007;44:223–245.17682344
   PubMed Web of Science ®Google Scholar
• HeS, LinK, MaR, XuR, XiaoY. Effect of the urinary trypsin inhibitor ulinastatin on cardiopulmonary bypass-related inflammatory response and clinical outcomes: a meta-analysis of randomized controlled trials. Clin Ther. 2015;37(3):643–653. doi:10.1016/j.clinthera.2014.12.01525660078
   PubMed Web of Science ®Google Scholar
• HeQL, ZhongF, YeF, et al. Does intraoperative ulinastatin improve postoperative clinical outcomes in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Biomed Res Int. 2014;2014:630835. doi:10.1155/2014/63083524734237
   PubMed Web of Science ®Google Scholar
• ChenHM, HuangHS, RuanL, HeYB, LiXJ. Ulinastatin attenuates cerebral ischemia-reperfusion injury in rats. Int J Clin Exp Med. 2014;7(5):1483–1489.24995117
   PubMed Web of Science ®Google Scholar
• FanH, ZhaoY, ZhuJH, YeJH, YaoXQ. Ulinastatin and thymosin a1 therapy in adult patients with severe sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Iran J Public Health. 2016;45(9):1234–1235.27957473
   PubMed Web of Science ®Google Scholar
• von VietinghoffS, KoltsovaEK. Inflammation in atherosclerosis: a key role for cytokines. Cytokine. 2019;122:154819. doi:10.1016/j.cyto.2019.15481931447282
   PubMed Web of Science ®Google Scholar
• CaoT, ZhangL, YaoLL, et al. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype. Biochim Biophys Acta. 2017;1863(11):2772–2782. doi:10.1016/j.bbadis.2017.07.002
   Web of Science ®Google Scholar
• ZhuLH, HuangL, ZhangX, et al. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation. Clin Sci (Lond). 2015;129(2):129–145. doi:10.1042/CS2014067925751394
   PubMed Web of Science ®Google Scholar
• ChistiakovDA, OrekhovAN, BobryshevYV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015;214(1):33–50.25677529
   PubMed Web of Science ®Google Scholar
• HaJM, YunSJ, KimYW, et al. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1. Biochem Biophys Res Commun. 2015;464(1):57–62. doi:10.1016/j.bbrc.2015.05.09726032503
   PubMed Web of Science ®Google Scholar
• ShawkyNM, SegarL. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation. Pharmacol Res. 2017;119:251–264. doi:10.1016/j.phrs.2017.02.01028212891
   PubMed Web of Science ®Google Scholar
• LuQB, WanMY, WangPY, et al. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFkappaB/mTOR/P70S6K signaling cascade. Redox Biol. 2018;14:656–668. doi:10.1016/j.redox.2017.11.01229175753
   PubMed Web of Science ®Google Scholar
• ZhangN, ZhangY, YouS, et al. Septin4 prevents PDGF-BB-induced HAVSMC phenotypic transformation, proliferation and migration by promoting SIRT1-STAT3 deacetylation and dephosphorylation. Int J Biol Sci. 2020;16(4):708–718. doi:10.7150/ijbs.3984332025217
   PubMed Web of Science ®Google Scholar
• HamiltonCA, BrosnanMJ, McIntyreM, GrahamD, DominiczakAF. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001;37(2 Pt 2):529–534. doi:10.1161/01.HYP.37.2.52911230330
   PubMed Web of Science ®Google Scholar
• HiroseJ, OzawaT, MiuraT, et al. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull. 1998;21(7):651–656. doi:10.1248/bpb.21.6519703243
   PubMed Web of Science ®Google Scholar
• KarnadDR, BhadadeR, VermaPK, et al. Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med. 2014;40(6):830–838. doi:10.1007/s00134-014-3278-824737258
   PubMed Web of Science ®Google Scholar
• InamoY, OkuboT, WadaM, et al. Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients. Three case reports. Int Arch Allergy Immunol. 2002;127(1):89–94. doi:10.1159/00004817411893859
   PubMed Web of Science ®Google Scholar
• RibeiroJK, CunhaDD, FookJM, SalesMP. New properties of the soybean trypsin inhibitor: inhibition of human neutrophil elastase and its effect on acute pulmonary injury. Eur J Pharmacol. 2010;644(1–3):238–244. doi:10.1016/j.ejphar.2010.06.06720624384
   PubMed Web of Science ®Google Scholar
• LimYP, BendeljaK, OpalSM, SiryapornE, HixsonDC, PalardyJE. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis. 2003;188(6):919–926. doi:10.1086/37764212964125
   PubMed Web of Science ®Google Scholar
• ShigetomiH, OnogiA, KajiwaraH, et al. Anti-inflammatory actions of serine protease inhibitors containing the kunitz domain. Inflamm Res. 2010;59(9):679–687. doi:10.1007/s00011-010-0205-520454830
   PubMed Web of Science ®Google Scholar
• MasudaT, SatoK, NodaC, et al. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med. 2003;31(7):1987–1992. doi:10.1097/01.CCM.0000057037.44171.BA12847393
   PubMed Web of Science ®Google Scholar
• DengY, KongJ. Urinary trypsin inhibitor reduced inflammation response induced by hyperlipidemia. J Cardiovasc Pharmacol Ther. 2015;20(6):572–578.25896908
   PubMed Web of Science ®Google Scholar
• LiaoXH, WangN, ZhaoDW, et al. STAT3 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J Biol Chem. 2015;290(32):19641–19652. doi:10.1074/jbc.M114.63011126100622
   PubMed Web of Science ®Google Scholar
• AlexanderMR, OwensGK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74(1):13–40. doi:10.1146/annurev-physiol-012110-14231522017177
   PubMed Web of Science ®Google Scholar
• OwensGK, KumarMS, WamhoffBR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3):767–801.15269336
   PubMed Web of Science ®Google Scholar
• JiangF, WangH, BaoS, et al. Thyrotropin regulates eNOS expression in the endothelium by PGRN through Akt pathway. Front Endocrinol (Lausanne). 2018;9:353. doi:10.3389/fendo.2018.0035330026730
   PubMed Web of Science ®Google Scholar
• DiamantM, TushuizenME. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD. Curr Diab Rep. 2006;6(4):279–286. doi:10.1007/s11892-006-0061-416879779
   PubMedGoogle Scholar
• ChenouF, AlbuquerqueDM, LeonardoDP, et al. Endothelial nitric oxide synthase (eNOS) gene polymorphisms and markers of hemolysis, inflammation and endothelial dysfunction in brazilian sickle cell anemia patients. Biochem Genet. 2020;58(4):580–594. doi:10.1007/s10528-020-09959-w32277314
   PubMed Web of Science ®Google Scholar
• HilgersRH, Kundumani-SridharanV, SubramaniJ, et al. Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function. Sci Transl Med. 2017;9(376):eaaf6094. doi:10.1126/scitranslmed.aaf609428179506
   PubMed Web of Science ®Google Scholar
• LundbergJO, GladwinMT, WeitzbergE. Strategies to increase nitric oxide signalling in cardiovascular disease. Nat Rev Drug Discov. 2015;14(9):623–641.26265312
   PubMed Web of Science ®Google Scholar